SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending following its recent expansion into U.S.-made regulated pharmaceutical products and renewed speculation about significant government contracts for domestic API manufacturing. The community is highly anticipating a "Kodak moment" surge, linking the company's strengthened balance sheet and strategic pivot to national security priorities for pharmaceutical supply chains.

Moo Deng

MOODENG CRYPTO is experiencing heightened community speculation and trading volume, driven by its history of explosive price movements and a low market cap on platforms like Robinhood. Traders are actively debating its potential for another significant rally amidst wider crypto market sentiment, even as some question its volatility and see it as a pump-and-dump asset.

Eagle Materials, Inc. engages in the provision of heavy construction materials and light building materials. It operates through the following business segments: Cement, Concrete and Aggregates, Gypsum Wallboard, and Recycled Paperboard. The Cement segment deals with the manufacture, production, distribution, and sale of Portland cement. The Concrete and Aggregates segment is involved in mixing cement, sand, gravel, or crushed stone and water to form concrete, which is then sold and distributed to construction contractors. The Gypsum Wallboard segment mines and extracts natural gypsum rock, which is used in the manufacture of gypsum wallboard. The Recycled Paperboard segment processes paper fiber, water, and paper chemicals to form recycled paperboards that are sold to gypsum wallboard manufacturers. The company was founded in 1963 and is headquartered in Dallas, TX.

Eagle Materials Inc.

Eagle Materials is trending due to mixed analyst actions, including a recent downgrade by JP Morgan, and a past earnings miss that has fueled divided community sentiment. While some investors perceive the stock as undervalued given its record sales and profitability, others emphasize its volatility and execution risks within the broader construction materials sector, which has faced weather-related impacts.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI CRYPTO is trending as its dedicated community rallies around the "We're All Gonna Make It" mantra, emphasizing ongoing building, new partnerships, and strengthened liquidity with USDC and USDT pools on Solana.

Codatta

XNY (Codatta) is garnering significant community attention for its strong market performance, often outperforming Bitcoin, and its core utility in powering AI's data future with features like on-chain fingerprint verification. Traders are actively discussing its potential to break key resistance levels and achieve new highs.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

PENGU is trending following its high-profile advertising campaign on the Las Vegas Sphere and recent collaborations with brands like the NHL and Care Bears, signaling a push for mainstream integration. While many in the community are buying the dip and bullish on its real-world utility and long-term brand potential, others remain cautious of its price volatility amidst broader meme coin market trends.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa Inc. ($V) is trending due to recent strong earnings and strategic moves into AI-driven commerce and stablecoin settlements, though its stock has seen volatility amid intense community debate over proposed credit card interest rate caps. Many investors are weighing the impact of these regulatory discussions against Visa's transaction-based revenue model, often viewing market reactions as an oversold buying opportunity.

Smithfield Foods, Inc. operates as a meat-processing company. The firm processes and produces pork and hog. Its brands include Smithfield, Eckrich, Nathan's Famous, Farmland, and Armour. The company was founded by Joseph Williamson Luter, Sr. and Joseph Williamson Luter, Jr. in 1936 and is headquartered in Smithfield, VA.

Smithfield Foods, Inc.

Smithfield Foods Inc.

Smithfield Foods is trending due to its strategic acquisition of the Nathan's Famous hot dog brand, alongside a series of strong earnings reports and analyst upgrades. The community is actively discussing the company's solid fundamentals and defensive sector appeal, while some express reservations about its foreign ownership.

Coterra Energy Inc. is an independent oil and gas company engaged in the development, exploration and production of oil, natural gas, and Natural Gas Liquids. Its portfolio includes projects in the Permian Basin, the Marcellus Shale, and the Anadarko Basin. Coterra Energy was founded in 1989 and is headquartered in Houston, TX.

Coterra Energy Inc

Coterra Energy is trending due to its announced all-stock merger with Devon Energy, set to create a major U.S. shale producer. The community is actively discussing how this transformative deal is expected to reshape the shale landscape, emphasizing the combined entity's increased scale, synergies, and focus on the Delaware Basin.

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Bio-Techne Corp

Bio-Techne is trending as investors consider its mixed financial performance, with recent earnings illustrating revenue pressures amidst a challenging biotech funding environment. Despite these sector-wide headwinds, the community remains focused on Bio-Techne's strategic expansions in spatial biology and cell/gene therapy, driven by key partnerships and product innovations poised for future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shell Asset Management Co. Sells 4,478 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Shell Asset Management Co. cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 61.7% during the third quarter, according to the company in its most recent Form 13F filing...

Aberdeen Group plc Sells 61,228 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Aberdeen Group plc lessened its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 28.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...

12,116 Shares in Alnylam Pharmaceuticals, Inc. $ALNY Purchased by Cibc World Market Inc.

Cibc World Market Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Lowered to "Buy" Rating by Wall Street Zen

Wall Street Zen cut shares of Alnylam Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down

Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $425.00 at Chardan Capital

Chardan Capital lowered their target price on shares of Alnylam Pharmaceuticals from $475.00 to $425.00 and set a "buy" rating on the stock in a research note on Friday...

Rhumbline Advisers Sells 3,988 Shares of Alnylam Pharmaceuticals, Inc. $ALNY

Rhumbline Advisers decreased its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 2.0% in the third quarter, according to its most recent disclosure with the Securities...

Why Alnylam Pharmaceuticals Stock Slipped Today

Key PointsThe biotech released its final set of figures for 2025...

Needham & Company LLC Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price

Needham & Company LLC decreased their price objective on Alnylam Pharmaceuticals from $529.00 to $510.00 and set a "buy" rating for the company in a research report on Thursday...

Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Quarterly Earnings Results

Alnylam Pharmaceuticals (NASDAQ:ALNY - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported $0.82 EPS for the quarter, missing the consensus estimate of...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc